Skip to content
★ Sign in to follow
BN

Binh Nguyen

Executive
Endocyte Inc
Total declarations
8
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€348k

Latest filing published 05 Mar 2015 for ENDOCYTE INC, €127k.

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

No signal scores available.

Binh Nguyen: trading record in brief

This profile gathers the share dealings of Binh Nguyen in Endocyte Inc. The record holds 8 filings, for trades running from 17 May 2013 to 3 March 2015.

Sales make up the whole of the open-market record (2 sales, €348k). Outside the open market, there are 3 share grants and 3 option exercises. In 2015 alone, the filings show no purchases and 1 sale.

The record was last updated on 5 March 2015 with an option exercise (€127k) in Endocyte Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Binh Nguyen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ◇
    VP of Medical AffairsExecutivesEndocyte Inc
    142,000 USD0SEC
    40,000 shares@ US$3.55Common StockSEC:0001144204-15-014248:0
  • ▼
    VP of Medical AffairsExecutivesEndocyte Inc
    173,023 USD0SEC
    29,883 shares@ US$5.79Common StockSEC:0001144204-15-014248:1
  • ◆
    VP of Medical AffairsExecutivesEndocyte Inc
    0SEC
    8,750 shares0Common StockSEC:0001144204-15-006845:0
  • ◆
    VP of Medical AffairsExecutivesEndocyte Inc
    3,639 USD0SEC
    708 shares@ US$5.14Common StockSEC:0001144204-15-006845:1
  • ◆
    VP of Medical AffairsExecutivesEndocyte Inc
    0SEC
    7,500 shares0Common StockSEC:0001144204-14-007384:0
  • ◇
    VP of Clinical AffairsExecutivesEndocyte Inc
    9,585 USD0SEC
    2,700 shares@ US$3.55Common StockSEC:0001144204-13-031362:0
  • ◇
    VP of Clinical AffairsExecutivesEndocyte Inc
    61,415 USD0SEC
    17,300 shares@ US$3.55Common StockSEC:0001144204-13-030864:0
  • ▼
    VP of Clinical AffairsExecutivesEndocyte Inc
    249,466 USD0SEC
    17,300 shares@ US$14.42Common StockSEC:0001144204-13-030864:1

8 of 8 declarations